The Recall Desk
SevereFDA (Drugs)·D-1010-2020·Announced 2020-03-18

Redline Pharmacy Recalls Vancomycin Injectable Due to Processing Control Deficiencies

Redline Pharmacy Solutions is recalling 3 doses of Vancomycin 900MG Injectable due to a lack of processing controls. The product was sold to patients in Nebraska.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The FDA classified this recall as Class II. According to the severity rubric, an FDA Class II recall is assigned a score of 4 (Severe) unless specific hospitalization reports are present, which are not mentioned in the source text.

Plain-English summary

Redline Pharmacy Solutions is recalling 3 doses of Vancomycin 900MG in 100ML 0.9% NACL Injectable. The recall is being conducted due to a lack of processing controls. The affected product is identified by Lot 02242020@8.

The recalled medication was distributed to patients in Nebraska. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.

Patients who have received this medication should contact their healthcare provider or pharmacist for further instructions on how to proceed.

The recalled product

Product
Vancomycin 900MG in 100ML 0.9% NACL Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
Affected units
3

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot 02242020@8

Distribution

Distributed in 1 state:

Part of a larger recall action

This product is one of 6 recalled by Redline Pharmacy Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 6 products in this recall →